Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care
Two experts urge caution with the results, but suggest dialing back liberal use of therapeutic anticoagulation unless in an RCT.
Related Articles
Top Policy and Practice News of 2024
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in cardiology this year.
TCTMD’s 2024 Cardiology Crossword Challenge
Welcome to cardiology’s jolliest—and most socially acceptable forum—for proving you paid attention to the top news of 2024! Submit your crossword answers, whether you’ve answered…
Most Memorable Stories of 2024
An annual tradition: TCTMD’s Yael Maxwell, Laura McKeown, Michael O’Riordan, Caitlin Cox, and Todd Neale describe their standout stories.
Some Guidance for Managing Patients With AS and CAD: Review
With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.
CV Health Starts to Decline Around Age 10
The findings underscore the message that “it’s never too early to think about your heart health.”
Downsizing, Underexpansion Common in Redo TAVI With Sapien 3
This small study suggests there’s much still to learn about how best to handle the complexity of repeat procedures.
Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
December 2024 News Roundup
This month: texts fail to up adherence, unstable AF risks, survival win for SGLT2 therapy in real-world HFrEF patients, and more.
BMJ Investigation Revives Questions About PLATO, Ticagrelor
PLATO investigators dismiss the paper as nothing new, but some clinicians say that, after 15 years, it’s hard not to have doubts.
Radial Artery Best for Secondary Access During TAVI: PULSE Registry
Complication rates, including bleeding, were significantly lower when the radial artery was used over a second femoral puncture.